Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug‐Target Mendelian Randomization Study

BACKGROUND: PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors are important therapeutic options for reducing cardiovascular disease risk; however, questions remain regarding potential differences in the neuropsychiatric impact of long‐term PCSK9 inhibition between men and women. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Andrew S., Rosoff, Daniel B., Mavromatis, Lucas A., Jung, Jeesun, Wagner, Josephin, Lohoff, Falk W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673626/
https://www.ncbi.nlm.nih.gov/pubmed/36285785
http://dx.doi.org/10.1161/JAHA.122.026122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673626/
https://www.ncbi.nlm.nih.gov/pubmed/36285785
http://dx.doi.org/10.1161/JAHA.122.026122

Ejemplares similares